-
2022-502176-23-01
4
2024-05-13
Migraine
-
2022-502177-42-02
4
2024-05-13
Chronic migraine
-
2023-510228-63-00
4
2024-05-01
Multiple sclerosis
-
2023-504374-38-00
5
2024-04-12
Locally advanced cervical cancer
-
2023-504899-25-00
5
2024-04-04
Metastatic castration resistant prostate cancer
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2023-505267-36-00
5
2024-03-15
Glioblastoma
-
2023-504735-41-00
5
2024-03-05
Moderately to Severely Active Crohn's Disease
-
2023-505254-17-00
6
2023-11-03
Osteoarthritis in first carpometacarpal joint
-
2022-500586-27-00
6
2023-08-15
Chronic wet cough in young children
-
2024-512888-31-00
11
2023-08-03
Primary adrenal insufficiency (PAI)
-
2023-504999-25-00
5
2023-07-14
Acute Myeloid Leukemia
-
2022-501504-95-00
4
2023-06-23
Non-metastatic HER2-positive Breast Cancer
-
2022-501600-10-00
5
2023-02-07
Atrial fibrillation and Chronic Kidney Disease stage 5
-
2023-506239-14-00
5
2022-12-13
Crohn’s Disease
-
2023-503442-30-00
5
2022-10-14
Multiple Myeloma
-
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
-
2023-503174-20-00
4
2022-05-30
KRAS G12C-mutated non-small cell lung cancer
-
2023-506891-28-00
5
2022-05-02
The target population of interest in this study is participants with l
-
2024-510798-84-00
10
2022-01-28
Idiopathic sudden sensorineural hearing loss (ISSNHL)
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-518177-33-00
7
2021-10-01
Cancer Anorexia
-
2024-512276-35-00
4
2021-08-09
Multiple Myeloma
-
2023-507894-16-00
4
2021-04-01
Cancer